The global compression therapy market size was valued at USD 4.25 billion in 2024 and is projected to reach USD 5.34 billion by 2030, registering a CAGR of 3.8% from 2025 to 2030. This steady growth is driven by the rising prevalence of vein-related disorders, including leg ulcers, Deep Vein Thrombosis (DVT), lymphedema, varicose veins, and blood clots. These conditions are becoming increasingly common due to factors such as aging populations, sedentary lifestyles, and the growing incidence of obesity, all of which contribute to compromised venous circulation.

The market is currently at a moderate growth stage, but the overall pace of expansion is accelerating. The high growth potential is fueled not only by the increasing number of chronic vein disorder cases but also by the rising volume of orthopedic surgeries and postoperative care needs, where compression therapy plays a critical role in improving blood flow, reducing swelling, and promoting faster recovery.

Market players are adopting a range of strategic initiatives to strengthen their position, including new product launches, geographic expansions, acquisitions, partnerships, and technological collaborations. For example, in October 2023, Medi GmbH & Co. introduced Medi Rehab, a new line of compression stockings available in both thigh-length and calf-length versions, with options for open or closed toes. The open-toe calf stocking design is particularly suited for conservative or postoperative treatment of ankle joint injuries or Achilles tendon ruptures, as it allows patients to easily put on and remove the stockings without discomfort.

Key Market Trends & Insights:

• North America dominated the global compression therapy market in 2024, holding a revenue share of 42.43%. The region’s strong market position is attributed to advanced healthcare infrastructure, high awareness about vein health, and the presence of leading manufacturers.
• The Asia Pacific market is forecast to experience the fastest CAGR during the study period, driven by increasing healthcare investments, rising awareness of venous disorders, and growing adoption of home-based healthcare solutions.
• The static compression therapy segment accounted for the largest revenue share of 69.08% in 2024. Static compression products such as bandages, stockings, and wraps are widely used due to their cost-effectiveness and ease of use. The dynamic compression therapy segment is projected to grow at the fastest rate during the forecast period, supported by technological innovations in pneumatic compression devices and targeted therapy systems.
• The hospitals segment led the market in 2024, reflecting the high number of inpatient treatments for venous and orthopedic conditions. The home healthcare segment is expected to record the fastest CAGR, driven by the shift towards self-care and increasing demand for portable compression devices.
• Institutional sales represented the largest share of revenue in 2024, due to bulk procurement by hospitals, clinics, and rehabilitation centers. The retail sales segment is expected to witness the fastest growth, as more patients purchase compression therapy products directly from pharmacies, online platforms, and specialty stores.

Order a free sample PDF of the Compression Therapy Market Intelligence Study, published by Grand View Research.

Market Size & Forecast:

• 2024 Market Size: USD 4.25 Billion
• 2030 Projected Market Size: USD 5.34 Billion
• CAGR (2025-2030): 3.8%
• North America: Largest market in 2024
• Asia Pacific: Fastest growing market

Key Companies & Market Share Insights:

Prominent players in the global compression therapy market include Cardinal Health, Julius Zorn GmbH, 3M Health Care, Spectrum Healthcare, Bio Compression Systems, Inc., Stryker, and Gottfried Medical. These companies provide a comprehensive range of products, such as compression garments, stockings, wraps, and mechanical devices, targeting conditions like venous insufficiency, lymphedema, and chronic wound management.

The competitive landscape is also being shaped by emerging players and startups, many of which focus on niche market segments or introduce novel compression technologies. Such companies are disrupting conventional market approaches by offering highly specialized solutions tailored to wound care management and vascular health. Manufacturers are increasingly focused on patient-centric solutions, prioritizing comfort, ease of use, and convenience to improve patient adherence and overall treatment effectiveness.

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion:

In conclusion, the global compression therapy market is set for steady growth, driven by rising cases of venous disorders, increasing orthopedic procedures, and technological advancements. North America leads in market share, while Asia Pacific is expected to grow fastest. Innovation, patient comfort, and expanding home healthcare adoption will remain key growth drivers through 2030.